rs199472681

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_SupportingPM2PP5

The NM_001406837.1(KCNQ1):​c.3G>A​(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 32)

Consequence

KCNQ1
NM_001406837.1 start_lost

Scores

13
4
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1O:1

Conservation

PhyloP100: 6.93
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PVS1
Start lost variant, no pathogenic variants between lost start and next in-frame start position. Next in-frame start position is after 69 codons. Genomic position: 2528016. Lost 0.116 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-2445463-G-A is Pathogenic according to our data. Variant chr11-2445463-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 53039.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=1, not_provided=1}. Variant chr11-2445463-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ1NM_000218.3 linkc.365G>A p.Cys122Tyr missense_variant Exon 1 of 16 ENST00000155840.12 NP_000209.2 P51787-1Q96AI9
KCNQ1NM_001406837.1 linkc.3G>A p.Met1? start_lost Exon 1 of 17 NP_001393766.1
KCNQ1NM_001406836.1 linkc.365G>A p.Cys122Tyr missense_variant Exon 1 of 15 NP_001393765.1
KCNQ1NM_001406838.1 linkc.365G>A p.Cys122Tyr missense_variant Exon 1 of 11 NP_001393767.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkc.365G>A p.Cys122Tyr missense_variant Exon 1 of 16 1 NM_000218.3 ENSP00000155840.2 P51787-1
KCNQ1ENST00000345015.4 linkn.142G>A non_coding_transcript_exon_variant Exon 1 of 3 1
KCNQ1ENST00000496887.7 linkc.104G>A p.Cys35Tyr missense_variant Exon 2 of 16 5 ENSP00000434560.2 E9PPZ0
KCNQ1ENST00000646564.2 linkc.365G>A p.Cys122Tyr missense_variant Exon 1 of 11 ENSP00000495806.2 A0A2R8YEQ9

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Nov 26, 2013
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Cys122Tyr (TGC>TAC): c.365 G>A in exon 1 of the KCNQ1 gene (NM_000218.2). The Cys122Tyr mutation in the KCNQ1 gene has been reported in association with LQTS and Jervell and Lange-Nielson syndrome (JLNS) (Tester D et al., 2005; Giudicessi et al., 2012; Giudicessi et al., 2013). Tester et al. and Giudicessi et al. (2012) each reported Cys122Tyr in an individual with LQTS and it was absent from more than 1,500 control alleles. Giudicessi et al. (2013) identified Cys122Tyr in a patient, who harbored another mutation in the KCNQ1 gene, with a history of deafness and LQTS. Cys122Tyr was inherited from an asymptomatic mother. Cys122Tyr results in a conservative amino acid substitution of one neutral, polar amino acid with another at a position that is conserved across species. Furthermore, the Cys122Tyr mutation was not observed inapproximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, Cys122Tyr in the KCNQ1 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s). -

Long QT syndrome Uncertain:1
Apr 25, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been reported to affect KCNQ1 protein function (PMID: 29532034). This variant has been observed with a second variant in KCNQ1 in an individual affected with Jervell and Lange-Nielsen syndrome (PMID: 23392653). ClinVar contains an entry for this variant (Variation ID: 53039). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with tyrosine at codon 122 of the KCNQ1 protein (p.Cys122Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. -

Congenital long QT syndrome Other:1
-
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:19841300). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.50
D
BayesDel_noAF
Pathogenic
0.49
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.83
.;D;.
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D;D;D
M_CAP
Pathogenic
0.83
D
MetaRNN
Pathogenic
0.99
D;D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Benign
1.9
.;L;.
PrimateAI
Pathogenic
0.92
D
PROVEAN
Pathogenic
-7.4
D;D;.
REVEL
Pathogenic
0.93
Sift
Uncertain
0.0010
D;D;.
Sift4G
Pathogenic
0.0010
D;D;.
Polyphen
0.99
.;D;.
Vest4
0.96
MutPred
0.92
.;Loss of methylation at K121 (P = 0.027);.;
MVP
1.0
MPC
2.8
ClinPred
1.0
D
GERP RS
3.2
Varity_R
0.96
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199472681; hg19: chr11-2466693; API